TIMOLOL MONOTHERAPY IN THE TREATMENT OF UNCOMPLICATED ESSENTIAL-HYPERTENSION

被引：0
作者：
THIND, GS [1 ]
机构：
[1] UNIV LOUISVILLE, HLTH SCI CTR,SCH MED,DEPT MED,DIV CARDIOL, HYPERTENS UNIT, LOUISVILLE, KY 40202 USA
来源：
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1983年 / 33卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1046 / 1054
页数：9
相关论文
共 22 条
[1]  
AAGARD GN, 1982, HOSP FORMUL, V17, P311
[2]   SYSTEMIC EFFECTS OF EYE DROPS [J].
ADLER, AG ;
MCELWAIN, GE ;
MERLI, GJ ;
MARTIN, JH .
ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (13) :2293-2294
[3]   TIMOLOL PHARMACOKINETICS AND EFFECTS ON HEART-RATE AND BLOOD-PRESSURE AFTER ACUTE AND CHRONIC ADMINISTRATION [J].
BOBIK, A ;
JENNINGS, GL ;
ASHLEY, P ;
KORNER, PI .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (04) :243-249
[4]   THE CLINICAL IMPORTANCE OF CARDIOSELECTIVITY AND LIPOPHILICITY IN BETA-BLOCKERS [J].
CRUICKSHANK, JM .
AMERICAN HEART JOURNAL, 1980, 100 (02) :160-178
[5]  
DAVIES RO, 1981, P TIMOLOL INTERCONTI, P35
[6]  
DRAYER JI, 1980, TOPICS HYPERTENSION, P464
[7]   PLASMA TIMOLOL LEVELS AFTER ORAL AND INTRAVENOUS ADMINISTRATION [J].
ELSE, OF ;
SORENSON, H ;
EDWARDS, IR .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (06) :431-434
[8]  
FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707
[9]   CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .4. ADVERSE-EFFECTS - CHOOSING A BETA-ADRENORECEPTOR BLOCKER [J].
FRISHMAN, W ;
SILVERMAN, R ;
STROM, J ;
ELKAYAM, U ;
SONNENBLICK, E .
AMERICAN HEART JOURNAL, 1979, 98 (02) :256-262
[10]  
FRISHMAN WH, 1982, NEW ENGL J MED, V306, P1456
123